Point72 Hong Kong LTD Axsome Therapeutics, Inc. Transaction History

Point72 Hong Kong LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$50.63 - $73.5 $10,834 - $15,729	-214 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$55.91 - $81.44 $10,455 - $15,229	187 Added 692.59%	214 $12,000
Q4 2020 Feb 16, 2021	SELL	$66.31 - $86.52 $31,497 - $41,097	-475 Reduced 94.62%	27 $2,000
Q3 2020 Nov 16, 2020	SELL	$68.34 - $85.84 $84,468 - $106,098	-1,236 Reduced 71.12%	502 $36,000
Q2 2020 Aug 14, 2020	BUY	$49.87 - $98.69 $86,674 - $171,523	1,738 New	1,738 $143,000
Q1 2020 May 15, 2020	SELL	$41.2 - $101.31 $2,678 - $6,585	-65 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$16.71 - $106.24 $16,141 - $102,627	-966 Reduced 93.7%	65 $7,000
Q3 2019 Nov 14, 2019	BUY	$20.24 - $29.16 $20,867 - $30,063	1,031 New	1,031 $21,000

329

37.8M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $4.51B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.